United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
33.56%
Price
20.04.26
€486.70
Summary
This prediction is currently active. With a performance of 33.56% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -0.876% | -0.876% |
| iShares Core DAX® | 2,29 % | 9,96 % |
| iShares Nasdaq 100 | 4,54 % | 8,79 % |
| iShares Nikkei 225® | 2,81 % | 14,08 % |
| iShares S&P 500 | 3,10 % | 6,85 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
14.01%
20.04.26
20.04.26
